Sulforaphane for negative symptoms and memory in schizophrenia
Part of Mental health clinical trials.
This trial tests whether a natural supplement called sulforaphane can help reduce negative symptoms (like lack of motivation or social withdrawal) and improve thinking skills in people with schizophrenia. It is designed for those who are not in an acute phase and have had symptoms for at least 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have schizophrenia diagnosed by a doctor using the DSM-5 criteria
- You are in a stable phase (no relapse now) and have had negative symptoms for at least 6 months
- You have been on the same antipsychotic medicine(s) for a while and are not taking more than 2 antipsychotics
- You do not have major depression, severe anxiety, or other brain conditions
- You are not pregnant or breastfeeding, and not using certain supplements or medicines that affect thinking
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of brain stimulation called temporal interference to see if it can help with negative symptoms (like lack of motivation or emotion) and cognitive symptoms (like trouble with memory or focus) in schizophrenia. It uses a special head device to target a specific brain area.
This trial tests if a supplement called PQQ can help with cognitive problems and negative symptoms (like lack of motivation) in people with schizophrenia. It may offer a new way to support current treatment.
This trial tests if berberine, a natural supplement, can help reduce negative symptoms like lack of motivation or social withdrawal in people with schizophrenia. It may work by affecting the brain and body.
This study tests a new treatment that may help with thinking and memory problems in people with schizophrenia. It is for people whose schizophrenia symptoms are stable and who are already on a steady medication.
This trial tests if a new treatment, xanomeline/trospium (XT), can help improve thinking and memory problems in adults with schizophrenia. You would take XT as a tablet alongside your current medication for up to 52 weeks.
This Phase 2 trial tests whether a “synbiotic” supplement (a mix of probiotics and prebiotics) can reduce symptoms of schizophrenia or schizoaffective disorder. It may help by targeting gut-related immune and inflammation pathways that could affect brain symptoms.
Hear when a new Schizophrenia Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.